Live Breaking News & Updates on Cedric Ververken

Stay updated with breaking news from Cedric ververken. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Confo Therapeutics Secures VLAIO Grant Supporting Drug Discovery & Development in Endocrine and Metabolic Diseases

Confo Therapeutics Secures VLAIO Grant Supporting Drug Discovery & Development in Endocrine and Metabolic Diseases
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Valeria Fisher , Dennis Riedl , Cedric Ververken , Christel Menet , Trophic Communications , Confo Therapeutics , Flanders Innovation Entrepreneurship ,

Stephen Dowd

Stephen Dowd
pharmatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmatimes.com Daily Mail and Mail on Sunday newspapers.

Cedric Ververken , Stephen Dowd , Confo Therapeutics , Chief Business ,

Confo Therapeutics Appoints Dieter Weinand, Former CEO of Bayer Pharmaceuticals, as Independent Chairman

Confo Therapeutics Appoints Dieter Weinand, Former CEO of Bayer Pharmaceuticals, as Independent Chairman
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

New York , United States , Concordia College , Bristol Meyers Squibb , Dieter Weinand , John Berriman , Desmond James , Eli Lilly , Cedric Ververken , Bayer Ag , Trophic Communications , Board Of Bayer Pharmaceuticals , Long Island University , Confo Therapeutics , Independent Chairman , Bayer Pharmaceuticals , Global Primary Care Business , Weinandis Chairman , Nasdaq Listed Replimune , Aktien Sie ,

Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera

GHENT, Belgium, June 15, 2023 Confo Therapeutics, a leader in the discovery of medicines targeting G-protein coupled receptors (GPCRs), today announced that it has entered into a research collaboration with AbCellera for the discovery of therapeutic antibody candidates targeting two undisclosed GPCR targets. Confo will apply its proprietary ConfoBody® technology to stabilize the selected GPCRs in their disease-relevant conformations, which will then be used as antigens to enable antibody discov ....

Cedric Ververken , Confo Therapeutics , Vrije Universiteit Brussel ,